Equity Residential (NYSE:EQR) is one of the most undervalued stocks. On June 5, Stifel maintained a Buy rating on EQR with a ...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at ...

Financial services provider Stifel (NYSE:SF) announced on Thursday an increase in its May-end client assets, and estimated ...

Oracle (ORCL) shares rose more than 6% on Monday after CEO Safra Catz touted a "strong start" to fiscal 2026 and investment ...

According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.25%, which ...

The $1.5 billion settlement in 2003 and 2004 addressed a scandal over analysts issuing positive research to help Citigroup, ...

Stifel, Nicolaus & Company, Inc., has been ordered by a Finra arbitration panel to pay a family of four investors more than $132 million for breach of fiduciary and negligence tied to risky ...

One of the financial services company's top investment bankers is retiring after 16 years, but he'll still have a role with ...

Two employees of Stifel Financial Corp. in London departed the US investment bank after a probe into alleged inappropriate relationships with a cleaner.. Allegations about improper relationships ...

Equity Residential (NYSE:EQR) is one of the most undervalued stocks. On June 5, Stifel maintained a Buy rating on EQR with a price target of $69.01. The analysts highlighted that Q2 fundamentals ...

Analysts at Stifel reiterated their Buy rating on Vistagen Therapeutics, Inc. (NASDAQ:VTGN) with an unchanged price target of $12.00 post the company’s fiscal 2025 announcement.